×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [7]
Institute of Chi... [3]
THE STATE KEY LA... [3]
Authors
LEUNG CHUNG HANG [3]
SAN MING WANG [2]
HANMING SHEN [2]
Document Type
Journal article [7]
Other [1]
Date Issued
2023 [4]
2022 [2]
2021 [1]
Language
英語English [8]
Source Publication
Genes and Diseas... [6]
Genes & Diseases [2]
Indexed By
SCIE [4]
SSCI [1]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-8 of 8
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma
Journal article
Wang, Weidong, Lv, Wang, Wang, Hui, Xu, Yang, Yan, Junrong, Shen, Han Ming, Shan, Liqun, Hu, Jian. A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma[J]. Genes and Diseases, 2023, 10(6), 2241-2244.
Authors:
Wang, Weidong
;
Lv, Wang
;
Wang, Hui
;
Xu, Yang
;
Yan, Junrong
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
IF:
6.9
/
7.2
|
Submit date:2024/01/10
Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment
Journal article
Li,Guodong, Huang,Qi, Wai Wong,Vincent Kam, Wang,Wanhe, Leung,Chung Hang. Development of a dual targeting scaffold of SET7/MLL inhibitor for castration-resistant prostate cancer treatment[J]. Genes and Diseases, 2023, 10(6), 2260 - 2262.
Authors:
Li,Guodong
;
Huang,Qi
;
Wai Wong,Vincent Kam
;
Wang,Wanhe
;
Leung,Chung Hang
Favorite
|
TC[WOS]:
3
TC[Scopus]:
4
IF:
6.9
/
7.2
|
Submit date:2023/08/03
A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma
Other
2023-04-24
Authors:
Weidong Wang
;
Wang Lv
;
Hui Wang
;
Yang Xu
;
Junrong Yan
; et al.
Favorite
|
TC[WOS]:
0
TC[Scopus]:
0
|
Submit date:2023/08/03
Etiological roles of core promoter variation in triple-negative breast cancer
Journal article
Huang, Teng, Li, Jiaheng, Wang, San Ming. Etiological roles of core promoter variation in triple-negative breast cancer[J]. Genes & Diseases, 2023, 10(1), 228 - 238.
Authors:
Huang, Teng
;
Li, Jiaheng
;
Wang, San Ming
Favorite
|
TC[WOS]:
2
TC[Scopus]:
3
IF:
6.9
/
7.2
|
Submit date:2022/05/17
Core Promoter
Rna-seq
Triple-negative Breast Cancer
Variation
Whole Exome Sequencing
The multifaceted role of placental growth factor in the pathogenesis and progression of bronchial asthma and pulmonary fibrosis: Therapeutic implications
Journal article
Huang, Dan, Liu, Gege, Xu, Zhiyi, Chen, Shushu, Wang, Cuili, Liu, Dewei, Cao, Jiahao, Cheng, Junfen, Wu, Bin, Wu, Dong. The multifaceted role of placental growth factor in the pathogenesis and progression of bronchial asthma and pulmonary fibrosis: Therapeutic implications[J]. Genes and Diseases, 2022.
Authors:
Huang, Dan
;
Liu, Gege
;
Xu, Zhiyi
;
Chen, Shushu
;
Wang, Cuili
; et al.
Favorite
|
TC[WOS]:
4
TC[Scopus]:
4
|
Submit date:2023/01/30
AHR
Airway remodeling
Bronchial asthma
Chronic airway inflammation
PlGF
Development of an orally bioavailable selective inhibitor of the menin-MLL
Journal article
Zhong, Hai Jing, Wang, Wanhe, Zhou, Wei, Liang, Jia Xin, Cheng, Yung Chi, Ma, Dik Lung, Leung, Chung Hang. Development of an orally bioavailable selective inhibitor of the menin-MLL[J]. Genes and Diseases, 2022, 10(5), 1735-1738.
Authors:
Zhong, Hai Jing
;
Wang, Wanhe
;
Zhou, Wei
;
Liang, Jia Xin
;
Cheng, Yung Chi
; et al.
Favorite
|
TC[WOS]:
1
TC[Scopus]:
1
IF:
6.9
/
7.2
|
Submit date:2023/01/30
Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein–protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells
Journal article
Shasha Cheng, Guan-Jun Yang, Wanhe Wang, Dik-Lung Ma, Chung-Hang Leung. Discovery of a tetrahydroisoquinoline-based CDK9-cyclin T1 protein–protein interaction inhibitor as an anti-proliferative and anti-migration agent against triple-negative breast cancer cells[J]. Genes & Diseases, 2021, 9(6), 1674-1688.
Authors:
Shasha Cheng
;
Guan-Jun Yang
;
Wanhe Wang
;
Dik-Lung Ma
;
Chung-Hang Leung
Favorite
|
TC[WOS]:
23
TC[Scopus]:
26
IF:
6.9
/
7.2
|
Submit date:2022/05/13
Cancer Stem Cells
Cdk9-cyclin T1
Epithelial Mesenchymal Transition
Protein–protein Interaction (Ppi)
Triple-negative Breast Cancer (Tnbc)
Highly mutable core promoters in triple-negative breast cancer
Journal article
Wang, S. M.. Highly mutable core promoters in triple-negative breast cancer[J]. Genes and Diseases.
Authors:
Wang, S. M.
Favorite
|
|
Submit date:2022/07/27
promoter
mutation
cancer
expression